Boosting brain glucose metabolism to fight neurodegeneration?
Department of Translational Neuroscience and Centre for Biomedical Networked Research on Neurodegenerative Diseases, Neurodegeneration Group, Spain.|Cajal Institute, CSIC, Madrid, Spain.
María L
ML
de Ceballos
CNC-Center for Neurosciences and Cell Biology of Coimbra and Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal.
Attila
A
Köfalvi
D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001095:Arachidonic Acids / Q000737:chemistry; D001921:Brain / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000378:metabolism; D003704:Dementia / Q000378:metabolism; D063388:Endocannabinoids / Q000737:chemistry; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism*; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D008024:Ligands; D051379:Mice; D008822:Mice, Transgenic; D019636:Neurodegenerative Diseases / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism; D053284:Polyunsaturated Alkamides / Q000737:chemistry; D049268:Positron-Emission Tomography; D017510:Protein Folding; D043885:Receptor, Cannabinoid, CB2 / Q000378:metabolism*; D015398:Signal Transduction
D016229:Amyloid beta-Peptides; D001095:Arachidonic Acids; D063388:Endocannabinoids; D007328:Insulin; D008024:Ligands; D053284:Polyunsaturated Alkamides; D043885:Receptor, Cannabinoid, CB2; D019788:Fluorodeoxyglucose F18; D051546:Cyclooxygenase 2; D005947:Glucose; C078814:anandamide
18FDG-PET; Alzheimer’s disease; cannabinoid CB2 receptor; hypometabolism